Rojina Duwal

Rojina Duwal is a skilled research associate at Neogene Therapeutics since January 2022, with previous experience as a graduate student at Radboud University Nijmegen from September 2019 to October 2021. During tenure at Radboud Institute for Molecular Life Sciences, Rojina designed studies to enhance intraperitoneal NK cell therapy in ovarian cancer, optimized promoters for chimeric antigen receptors in T cells, and explored LDL's role in monocyte differentiation. Earlier internships at the Kathmandu Institute of Applied Sciences involved developing a smartphone microscopic assay for pathogen detection and collaborating on an NSF-USA project. Rojina holds a Master's degree in Molecular Mechanisms of Disease from Radboud University and a Bachelor’s degree in Biotechnology from Kathmandu University.